|
|
||||||||
The Journal of Immunology, Vol 147, Issue 7 2196-2201, Copyright © 1991 by American Association of Immunologists
ARTICLES |
C Kudo, A Araki, K Matsushima and F Sendo
Department of Parasitology, Yamagata University School of Medicine, Japan.
IL-8 recruits both neutrophils and lymphocytes in vitro and in vivo. To elucidate the mechanisms of lymphocyte recruitment in vivo by IL-8, we examined the role of neutrophil infiltration through selective depletion of circulating neutrophils using a mAb, RP-3. Selective depletion of neutrophils inhibited the IL-8 induced in vivo migration of the W3/25+ (CD4+) T cell subset but did not inhibit that of the MRC- OX8+ (CD8+) subset. These results suggest that CD4+ T cell migration into IL-8-injected s.c. tissues depends on the prior infiltration of neutrophils chemoattracted directly by IL-8.
This article has been cited by other articles:
![]() |
H. Tazawa, F. Okada, T. Kobayashi, M. Tada, Y. Mori, Y. Une, F. Sendo, M. Kobayashi, and M. Hosokawa Infiltration of Neutrophils Is Required for Acquisition of Metastatic Phenotype of Benign Murine Fibrosarcoma Cells: Implication of Inflammation-Associated Carcinogenesis and Tumor Progression Am. J. Pathol., December 1, 2003; 163(6): 2221 - 2232. [Abstract] [Full Text] |
||||
![]() |
N. Mukaida Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases Am J Physiol Lung Cell Mol Physiol, April 1, 2003; 284(4): L566 - L577. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, T. Douglass, E. W. B. Jeffes, Q. Xu, C. C. Williams, N. Arpajirakul, C. Delgado, M. Kleinman, R. Sanchez, Q. Dan, et al. Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a "paraptosis"-induced pathway that promotes systemic immunity against intracranial T9 gliomas Blood, July 30, 2002; 100(4): 1373 - 1380. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. McColl, M. A. Staykova, A. Wozniak, S. Fordham, J. Bruce, and D. O. Willenborg Treatment with Anti-Granulocyte Antibodies Inhibits the Effector Phase of Experimental Autoimmune Encephalomyelitis J. Immunol., December 1, 1998; 161(11): 6421 - 6426. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Taub, K Conlon, A. Lloyd, J. Oppenheim, and D. Kelvin Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta Science, April 16, 1993; 260(5106): 355 - 358. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |